Swiss Building Stock News

Why the Benton Rural Electric Agreement Matters for Landis+Gyr Group The new agreement with Benton Rural Electric Association puts Landis+Gyr Group (SWX:LAND) and its Revelo platform in focus, as investors consider what broader adoption of grid-edge sensing could mean for the stock. Benton Rural Electric is rolling out Revelo meters, grid sensors and a hybrid Gridstream Connect network that uses RF Mesh IP and cellular links to support advanced metering, real-time grid visibility and remote...

ABB (SWX:ABBN) has posted Q2 2026 results with revenue of US$9.5b and basic EPS of US$0.66, set against trailing 12 month revenue of US$35.1b and EPS of US$2.69, while earnings grew 25.5% over the past year. The company has seen revenue move from US$30.8b to US$35.1b and EPS from US$2.12 to US$2.69 over the last five reported trailing periods, giving investors a clear line of sight on how top line and per share earnings have tracked into the current quarter. With net profit margin at 13.9%,...

The European market has been grappling with geopolitical tensions and energy market volatility, leading to a decline in major indices like the STOXX Europe 600. Despite these challenges, investors are keenly observing sectors that might offer resilience or growth potential amid such uncertainties. Penny stocks, often associated with smaller or newer companies, continue to present intriguing opportunities for those looking for growth at lower price points. While the term may seem outdated,...

Regulators in the United States and European Union have widened access to several gene therapies, with the European Commission approving Novartis (SWX:NOVN) product onasemnogene abeparvovec for a broader group of patients with 5q spinal muscular atrophy. See our latest analysis for Novartis. Against this backdrop, Novartis shares are trading at CHF123.26, with a 30 day share price return of 2.97% and year to date share price return of 13.60%. The 1 year total shareholder return of 36.07%...

DKSH Holding (SWX:DKSH) is in focus after its healthcare unit signed an agreement with Eli Lilly Export S.A. to sell, promote, and distribute Lilly’s pharmaceutical portfolio in Hong Kong and Macau. See our latest analysis for DKSH Holding. The Lilly agreement comes at a time when DKSH Holding’s momentum has been firm, with a 30 day share price return of 8.16% and a year to date share price return of 15.36%, while the 1 year total shareholder return of 18.60% points to steady longer term...

Alcon (SWX:ALC) is back in focus after announcing a non-exclusive collaboration with RxSight to co-develop adjustable presbyopia-correcting intraocular lenses. These lenses can be fine tuned after cataract surgery. See our latest analysis for Alcon. At a share price of CHF56.94, Alcon has seen short term momentum pick up, with a 1 month share price return of 8.42% and 7 day gain of 5.37%. However, the 1 year total shareholder return is down 17.89%, pointing to ongoing investor caution even as...

Nestlé (SWX:NESN) is in focus after Genpact announced a partnership with Nestlé Business Solutions to build a new Global Capability Center in Hyderabad, India, centered on AI driven process transformation. See our latest analysis for Nestlé. Nestlé’s 30 day share price return of 6% and year to date share price return of 9.71% suggest momentum has been improving, while the 1 year total shareholder return of 13.53% contrasts with weaker 3 and 5 year total shareholder returns. This indicates a...

As geopolitical tensions and energy market volatility continue to influence the European markets, the pan-European STOXX Europe 600 Index recently experienced a decline of 1.79%. In this fluctuating environment, identifying stocks that are estimated to be trading below their intrinsic value can offer potential opportunities for investors seeking to navigate these uncertain times.

Why analyst sentiment around ams-OSRAM stock just shifted Recent analyst upgrades and higher earnings estimates have put ams-OSRAM (SWX:AMS) back on many investors’ radar, as the stock’s performance and sentiment move in tandem with these revised expectations. See our latest analysis for ams-OSRAM. ams-OSRAM’s CHF18.69 share price reflects a mixed recent pattern, with the stock down 3.16% on a 1 day share price return and 4.89% on a 30 day share price return, yet still showing a 61.40% 90 day...

In July 2026, Roche Holding received US FDA Priority Review for Gazyva/Gazyvaro in primary membranous nephropathy, a condition with no FDA approved therapies. Roche also launched the cobas HDV test, described as the first fully automated, high throughput diagnostic assay for Hepatitis D Virus. Both developments add to Roche Holding's immunology and virology portfolio and target areas with significant unmet medical need. For investors tracking Roche Holding (SWX:ROP), these July 2026...

Amidst geopolitical tensions and energy market volatility, the European stock market has faced challenges, with the pan-European STOXX Europe 600 Index recently experiencing a decline. Despite these uncertainties, dividend stocks remain an attractive option for investors seeking steady income streams in fluctuating markets. A strong dividend stock typically combines reliable payouts with a resilient business model that can withstand economic pressures and adapt to changing conditions.

In July 2026, Genpact announced it had partnered with Nestlé Business Solutions to build a new AI-enabled Global Capability Center in Hyderabad, India, while Nestlé also began tailoring recipes for GLP-1 users and launched its SparX Innovation Hub in Dubai to speed AI-driven product development in the MENA region. Together, these moves highlight how Nestlé is pairing process automation with rapid, data-led product innovation to respond more precisely to evolving health-focused consumer...

Julius Bär Gruppe (SWX:BAER) has drawn investor attention after appointing Peter Burrill as Chief Financial Officer and Executive Board member, replacing Evie Kostakis. His start is planned for August 2026, pending regulatory clearance. See our latest analysis for Julius Bär Gruppe. At a share price of CHF74.72, Julius Bär Gruppe has seen firm momentum recently, with a 30 day share price return of 15.49% and a 90 day share price return of 20.52%, while the 1 year total shareholder return of...

As geopolitical tensions and energy market volatility weigh on European markets, the STOXX Europe 600 Index recently saw a decline, reflecting investor concerns over potential inflationary pressures and monetary policy adjustments. Amidst this backdrop, dividend stocks can offer a measure of stability and income potential for investors seeking to navigate uncertain times.

As geopolitical tensions and energy market volatility weigh on European equities, the pan-European STOXX Europe 600 Index has experienced a notable decline. Amidst these market dynamics, dividend stocks can offer investors a measure of stability and income potential, making them an attractive option in uncertain times.

As geopolitical tensions and energy market volatility shape the European financial landscape, investors are closely monitoring how these factors influence inflation and monetary policy expectations. Amidst this backdrop, growth companies with high insider ownership can offer unique insights into potential resilience and strategic alignment with shareholder interests.

A “super” El Niño expected in 2026–27 could rattle food supplies, push key crop prices sharply higher, and keep inflation pressure in play for years. For investors, that kind of shock can hurt some stocks tied to food and commodities while creating openings in others that are better positioned for price spikes and volatility. This article looks at three stocks that are closely exposed to the El Niño news, with one that could benefit from the setup and two where the risks may be more...

Cembra Money Bank has recently overhauled its organisation, creating a new Sales division, a Corporate Functions division and reshaping executive roles, including appointing a Chief Sales Officer and combining the CFO and Chief Risk Officer responsibilities. By consolidating core commercial activities and elevating compliance as an independent function, the bank is signalling a stronger push for integrated customer service while preserving an emphasis on risk and control. We’ll now examine...

Logitech International (SWX:LOGN) has drawn fresh attention after Logitech G was named the Official PC Peripheral Partner for Call of Duty: Modern Warfare 4, tying the stock story directly to premium gaming accessories. See our latest analysis for Logitech International. While Logitech International’s latest gaming partnership has caught the headlines, the share price tells a mixed story. The 7 day share price return is 6.77% and the 30 day share price return is down 6.43%. This is set...

Novartis (SWX:NOVN) has agreed to acquire UK based Myricx Bio, a privately held biotechnology company. Myricx Bio focuses on first in class N myristoyltransferase inhibitor (NMTi) antibody drug conjugate technology for cancer treatment. The deal adds a platform targeting HER2 and B7 H3 positive cancers, including certain treatment resistant tumors, to Novartis' oncology pipeline. For investors tracking large cap pharma, this move expands how Novartis is positioned within oncology, an area...

Logitech International S.A. recently announced it became the Official PC Peripheral Partner for Call of Duty: Modern Warfare 4, integrating Logitech G mice, keyboards, headsets, in-game items, and creator tools into the franchise’s ecosystem. The partnership extends beyond branding, tying Logitech G hardware, Streamlabs-powered creator experiences, and LIGHTSYNC RGB integrations directly into Modern Warfare 4’s “Play for Prestige” campaign, which could deepen gamer engagement with the...

Lonza Group (SWX:LONN) has been active on several fronts, with fresh agreements covering biologics manufacturing, central nervous system drug delivery research and antibody drug conjugate payload production capacity at its Visp site. See our latest analysis for Lonza Group. Lonza Group’s recent series of CNS partnerships, biologics expansions and ADC capacity investments has coincided with building momentum, with a 30-day share price return of 18.3% and a 1-year total shareholder return of...

In July 2026, European markets have shown resilience, with the pan-European STOXX Europe 600 Index rising by nearly 2% amid easing inflation concerns and stable unemployment rates. As investors navigate these conditions, growth companies with high insider ownership can present compelling opportunities due to their potential alignment of management interests with shareholders and the ability to capitalize on favorable economic developments.

As the pan-European STOXX Europe 600 Index recently advanced by 1.96%, bolstered by lower oil prices and easing inflation expectations, investor sentiment in Europe appears cautiously optimistic. In this environment, identifying undervalued stocks becomes crucial, as these opportunities may offer potential for growth when market conditions stabilize further.